Skip to main navigation
Sophiris

Main navigation

  • About
    • Management
    • Board of Directors
  • Science
    • Topsalysin
    • Prostate Cancer
    • BPH
  • Patients
    • Resources/Advocacy Groups
    • Clinical Trials
  • Publications
  • Investor
    • News
    • Events & Presentations
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Contact IR
  • News
  • Contact Us

Investor Relations

  • Overview
  • News
  • Events & Presentations
  • Corporate Governance
    • Corporate Governance Documents
    • Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financial Information
    • Annual Meeting Materials
    • SEC Filings
    • Sedar Filings
  • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
    • Analyst Coverage
    • Ownership Profile
  • Contact IR

News

News

  • Mar
    21
    2018
    Sophiris Bio Reports Fourth Quarter and Full Year 2017 Financial Results and Key Corporate Highlights
    Read
  • Mar
    15
    2018
    Sophiris Bio to Present at 17th Annual Needham Healthcare Conference
    Read
  • Dec
    27
    2017
    Sophiris Bio to Participate in the 10th Annual Biotech Showcase Conference
    Read
  • Dec
    11
    2017
    Sophiris Bio Announces Complete Enrollment in Phase 2b Topsalysin Study of Localized Prostate Cancer
    Read
  • Nov
    27
    2017
    Sophiris Bio to Participate in the 29th Annual Piper Jaffray Healthcare Conference
    Read
  • Nov
    09
    2017
    Sophiris Bio Reports Third Quarter Financial Results and Key Corporate Highlights
    Read
  • Oct
    02
    2017
    Sophiris Bio Provides Enrollment Update on Topsalysin Phase 2b Study in Localized Prostate Cancer
    Read
  • Sep
    13
    2017
    Sophiris Bio Secures up to $10 Million in Term Loans from Silicon Valley Bank
    Read
  • Aug
    17
    2017
    Sophiris Bio to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
    Read
  • Aug
    10
    2017
    Sophiris Bio Reports Second Quarter Financial Results and Key Corporate Highlights
    Read

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • …
  • Next page Next
  • Last page Last
Displaying 1 - 10 of 81 results

Shareholder Tools

  • Email Alerts
  • Printed Materials
  • RSS News Feeds
© Sophiris Bio Corp. 2017 All rights reserved
  • Terms and Conditions
@sophirisbio on Linkedin
MENU

Main navigation

  • About
    • Management
    • Board of Directors
  • Science
    • Topsalysin
    • Prostate Cancer
    • BPH
  • Patients
    • Resources/Advocacy Groups
    • Clinical Trials
  • Publications
  • Investor
    • News
    • Events & Presentations
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Contact IR
  • News
  • Contact Us